Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07408206 · ClinicalTrials.gov registry record · Early Phase 1

Sleep, Dreaming, and Virtual Reality for Mental Health

A Early Phase 1 study of Anxiety, sponsored by Northwestern University.

Recruiting
Registry status
Early Phase 1
Development phase
70
Enrollment target
2
Study locations

NCT07408206: Recruiting Early Phase 1 study of Anxiety, sponsored by Northwestern University.

NCT07408206 is a Early Phase 1 study of Anxiety that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 70 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07408206, a Early Phase 1 study of Anxiety, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
Early Phase 1
Development phase
70 participants
Enrollment target
2
Study locations

Study Summary

People spend approximately one-third of their lives asleep, yet sleep is often underused as an opportunity to support psychological well-being. Contemplative traditions, including Tibetan Dream Yoga, have developed practices that use waking imagination and lucid dreaming to explore perception, awareness, and habitual patterns of thinking. Recent advances in sleep monitoring, dream communication, and lucid dream induction now make it possible to study these practices using scientific methods. This study is a randomized controlled trial designed to examine the feasibility and effects of a Dream-Yoga-inspired intervention compared with an active control condition. The intervention combines waking and dreaming practices that are adapted for individuals without prior experience and delivered using virtual reality-based training and home sleep technology. The program is designed to be scalable and culturally neutral, without requiring prior knowledge of contemplative or religious traditions. The primary goals of the study are to characterize sleep and waking neurophysiology associated with Dream-Yoga-inspired practices and to evaluate whether participation is associated with changes in sleep-related brain activity and cognitive processes. Outcomes include measures of lucid dreaming, sleep physiology, and waking cognitive and perceptual processes. Anxiety will be assessed as an exploratory outcome to examine whether participation may be associated with changes in emotional experience. This study is not designed to provide treatment for anxiety or other clinical conditions. Results from this study will help inform the development of scalable sleep-based mental training approaches and guide future research on the use of dreaming and sleep practices to support psychological health and well-being.

Primary Outcome

The intervention will preferentially increase frontal midline theta during a short period of breath meditation (one recording session before and one after the intervention); EEG power band-passed at 4-10 Hz will be quantified and related to findings on self-referential processing (Nondual Awareness Dimensional Assessment)

Conditions Studied

Anxiety

Interventions

  • BEHAVIORAL Dream Yoga Inspired Intervention
  • BEHAVIORAL Sleep Health Enhancement Program (SHEP)

Study Locations (2)

Illinois

  • Northwestern University - Evanston

Virginia

  • Contemplative Sciences Center - Charlottesville

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2026-01-15
Est. Completion 2027-12-31
Phase Early Phase 1
Northwestern University

1,209 total trials

What NCT07408206 shows while recruiting

NCT07408206 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Dream Yoga Inspired Intervention is the first listed.

NCT07408206 reports a single indexed study location in Illinois, Virginia.

Frequently Asked Questions

What is clinical trial NCT07408206 about?

NCT07408206 is a clinical study titled "Sleep, Dreaming, and Virtual Reality for Mental Health". People spend approximately one-third of their lives asleep, yet sleep is often underused as an opportunity to support psychological well-being. Contemplative traditions, including Tibetan Dream Yoga, have developed practices that use waking imagination and lucid dreaming to explore perception, aware...

What is the current status of trial NCT07408206?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 70 participants. The study started on 2026-01-15. Estimated completion is 2027-12-31.

What conditions does trial NCT07408206 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT07408206?

The interventions under investigation include: Dream Yoga Inspired Intervention (BEHAVIORAL), Sleep Health Enhancement Program (SHEP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07408206?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07408206 being conducted?

This trial has 2 study locations across Illinois, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07408206's enrollment target sits among peer trials

70 215th of 364 higher than 148 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07408206

Source: ClinicalTrials.gov NCT07408206, the US trial registry maintained by the National Library of Medicine. NCT07408206 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.